Your browser doesn't support javascript.
loading
Scientific and Regulatory Policy Committee (SRPC) Points to Consider: Histopathology Evaluation of the Pubertal Development and Thyroid Function Assay (OPPTS 890.1450, OPPTS 890.1500) in Rats to Screen for Endocrine Disruptors.
Keane, Kevin A; Parker, George A; Regan, Karen S; Picut, Catherine; Dixon, Darlene; Creasy, Dianne; Giri, Dipak; Hukkanen, Renee R.
Afiliação
  • Keane KA; Novo Nordisk, Beijing, China.
  • Parker GA; WIL Research, Hillsborough, North Carolina, USA george.parker@wilresearch.com.
  • Regan KS; Regan Path/Tox Services, Inc, Ashland, Ohio, USA.
  • Picut C; WIL Research, Hillsborough, North Carolina, USA.
  • Dixon D; National Institute of Environmental Health Sciences, National Toxicology Program, Research Triangle Park, North Carolina, USA.
  • Creasy D; Dianne Creasy Consulting LLC, Pipersville, Pennsylvania, USA.
  • Giri D; Integrated Laboratory Systems, Raleigh-Durham, North Carolina, USA.
  • Hukkanen RR; The Dow Chemical Company, Midland, Michigan, USA Department of Comparative Medicine, University of Washington, Seattle, Washington, USA.
Toxicol Pathol ; 43(8): 1047-63, 2015 Dec.
Article em En | MEDLINE | ID: mdl-25948506
ABSTRACT
The U.S. Environmental Protection Agency Endocrine Disruptor Screening Program (EDSP) is a multitiered approach to determine the potential for environmental chemicals to alter the endocrine system. The Pubertal Development and Thyroid Function in Intact Juvenile/Peripubertal Female and Male Rats (OPPTS 890.1450, 890.1500) are 2 of the 9 EDSP tier 1 test Guidelines, which assess upstream mechanistic pathways along with downstream morphological end points including histological evaluation of the kidneys, thyroid, and select male/female reproductive tissues (ovaries, uterus, testes, and epididymides). These assays are part of a battery of in vivo and in vitro screens used for initial detection of test article endocrine activity. In this Points to Consider article, we describe tissue processing, evaluation, and nomenclature to aid in standardization of assay results across laboratories. Pubertal assay end points addressed include organ weights, estrous cyclicity, clinical pathology, hormonal assays, and histological evaluation. Potential treatment-related findings that may indicate endocrine disruption are reviewed. Additional tissues that may be useful in assessment of endocrine disruption (vagina, mammary glands, and liver) are discussed. This Points to Consider article is intended to provide information for evaluating peripubertal tissues within the context of individual assay end points, the overall pubertal assay, and tier I assays of the EDSP program.
Assuntos
Palavras-chave

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Função Tireóidea / Glândula Tireoide / Puberdade / Testes de Toxicidade / Disruptores Endócrinos Tipo de estudo: Evaluation_studies / Guideline Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Testes de Função Tireóidea / Glândula Tireoide / Puberdade / Testes de Toxicidade / Disruptores Endócrinos Tipo de estudo: Evaluation_studies / Guideline Limite: Animals Idioma: En Ano de publicação: 2015 Tipo de documento: Article